Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 63 Records) |
| Query Trace: Microsatellite Instability and POLE[original query] |
|---|
| Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study. European journal of cancer (Oxford, England : 1990) 2021 Aug 155 73-84. Antoniotti Carlotta, Korn W Michael, Marmorino Federica, Rossini Daniele, Lonardi Sara, Masi Gianluca, Randon Giovanni, Conca Veronica, Boccaccino Alessandra, Tomasello Gianluca, Passardi Alessandro, Swensen Jeff, Ugolini Clara, Oberley Matthew, Tamburini Emiliano, Casagrande Mariaelena, Domenyuk Valeriy, Fontanini Gabriella, Giordano Mirella, Abraham Jim, Spetzler David, Falcone Alfredo, Lenz Heinz-Josef, Cremolini Chia |
| IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
| Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors. Journal for immunotherapy of cancer 2021 10 9 (10): . Hwang Hee Sang, Kim Deokhoon, Choi Je |
| Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients. Frontiers in genetics 2021 12 608742. Zhu Chunrong, Zhu Liangjun, Gu Yanhong, Liu Ping, Tong Xiaoling, Wu Guozhong, Zhu Wenyu, Shen Wenxiang, Bao Hua, Ma Xiangyuan, Yu Ruoying, Wu Xue, Zhu Dongqin, Shu Yongqian, Feng Jife |
| Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation. Journal for immunotherapy of cancer 2022 7 10 (7): . Wen Lei, Chen Zhigang, Ji Xiaomeng, Fong William Pat, Shao Qiong, Ren Chao, Cai Yanyu, Li Binkui, Yuan Yunfei, Wang Deshen, Li Yuho |
| NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability. Cancer medicine 2022 5 11 (13): 2541-2549. Wang Hui, Li Zhi-Wei, Ou Qiuxiang, Wu Xue, Nagasaka Misako, Shao Yang, Ou Sai-Hong Ignatius, Yang |
| Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers. JCO precision oncology 2022 2 6 e2100267. Garmezy Benjamin, Gheeya Jinesh, Lin Heather Y, Huang Yuefan, Kim Taebeom, Jiang Xianli, Thein Kyaw Z, Pilié Patrick G, Zeineddine Fadl, Wang Wanlin, Shaw Kenna R, Rodon Jordi, Shen John Paul, Yuan Ying, Meric-Bernstam Funda, Chen Ken, Yap Timothy |
| Phase II study of durvalumab monotherapy in patients with previously treated microsatellite instability-high/mismatch repair-deficient or POLE-mutated metastatic or unresectable colorectal cancer. International journal of cancer 2022 Feb . Oh Chung Ryul, Kim Jeong Eun, Hong Yong Sang, Kim Sun Young, Ahn Joong Bae, Baek Ji Yeon, Lee Myung-Ah, Kang Myoung Joo, Cho Sang Hee, Beom Seung-Hoon, Kim Tae W |
| Mutational analysis of driver genes defines the colorectal adenoma: in situ carcinoma transition. Scientific reports 2022 02 12 (1): 2570. Jungwirth Jiri, Urbanova Marketa, Boot Arnoud, Hosek Petr, Bendova Petra, Siskova Anna, Svec Jiri, Kment Milan, Tumova Daniela, Summerova Sandra, Benes Zdenek, Buchler Tomas, Kohout Pavel, Hucl Tomas, Matej Radoslav, Vodickova Ludmila, van Wezel Tom, Vodicka Pavel, Vymetalkova Veroni |
| Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data. Frontiers in genetics 2022 13 963964. Jiang Miao, Jia Yongliang, Han Jinming, Shi Jianxiang, Su Chang, Zhang Rui, Xing Menglu, Jin Shuiling, Zong Ho |
| Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma. Frontiers in oncology 2022 1 11 798173. Liu Hangqi, Zhang Zhiwen, Chen Longyun, Pang Junyi, Wu Huanwen, Liang Zhiyo |
| Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods. Ginekologia polska 2022 1 . Bayramoglu Denizhan, Seçilmi? Kerimo?lu Özlem, Bayramo?lu Zeynep, Çintesun Ersin, ?ahin Gözde, Karaba?l? P?nar, Çelik Çet |
| Molecular characterization of endometrial carcinomas in Black and White patients reveals disparate drivers with therapeutic implications. Cancer discovery 2023 8 . Britta Weigelt, Antonio Marra, Pier Selenica, Eric Rios-Doria, Amir Momeni-Boroujeni, Michael F Berger, Kanika Arora, David Nemirovsky, Alexia Iasonos, Debyani Chakravarty, Nadeem R Abu-Rustum, Arnaud Da Cruz Paula, Kimberly Dessources, Lora H Ellenson, Ying L Liu, Carol Aghajanian, Carol L Bro |
| The Significance of FIGO Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial Carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 6 100234. Elizabeth Kertowidjojo, Amir Momeni-Boroujeni, Eric Rios-Doria, Nadeem Abu-Rustum, Robert A Sosl |
| Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide. Cancers 2023 4 15 (7): . Mustea Alexander, Ralser Damian J, Egger Eva, Ziehm Ulrike, Vivas Sonia, Brock Stephan, Jackson David, Condic Mateja, Meisel Christian, Otten Lucia, Laib Anna, Cordova Miguel Cubas, Hartmann Rahel, Stein Martin A, Koensgen Dominique, Stope Matthias |
| Germline pathogenic variants in patients with early onset neuroendocrine neoplasms. Endocrine-related cancer 2023 3 . Riechelmann Rachel Pimenta, Donadio Mauro D, Jesus Victor Hugo F de, de Carvalho Nathalia de Angelis, Santiago Karina Miranda, Barros Milton J, Lopes Laura, Santos Gabriel Oliveira Dos, Formiga Maria Nirvana, Carraro Dirce Maria, Torrezan Giovana Tard |
| Molecular Landscape of Mullerian Clear Cell Carcinomas Identifies The Cancer Genome Atlas-like Prognostic Subgroups. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 3 36 (5): 100123. Irshaid Lina, Costigan Danielle C, Dong Fei, Matulonis Ursula A, Nucci Marisa R, Kolin David |
| Adoption of Universal Testing in Endometrial Cancers for Microsatellite Instability Using Next-Generation Sequencing. JCO precision oncology 2023 10 7 e2300033. Isabel V Rodriguez, Sarah Strickland, David Wells, Enna Manhardt, Eric Q Konnick, Rochelle Garcia, Elizabeth Swisher, Mark Kilgore, Barbara Norqui |
| Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. Virchows Archiv : an international journal of pathology 2024 9 . Ben Davidson, Karin Teien Lande, Daniel Nebdal, Anne Jorunn Nesbakken, Arild Holth, Kristina Lindemann, Ane Gerda Zahl Eriksson, Therese Sørl |
| ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype. Molecular oncology 2024 7 . Melica Nourmoussavi Brodeur, Pier Selenica, Weining Ma, Sara Moufarrij, Christian Dagher, Thais Basili, Nadeem R Abu-Rustum, Carol Aghajanian, Qin Zhou, Alexia Iasonos, Lora H Ellenson, Britta Weigelt, M Herman Ch |
| Accelerated clinical response achieved by combining short-term tumor-directed photodynamic therapy with immunotherapy-based systemic therapies in synchronous colorectal cancer with MSI-H and POLE mutation: a case report. Frontiers in immunology 2024 7 15 1402334. Yuhan Wang, Lei Gao, Bin Ma, Jianming Shi, Zhenyu Yin, Weidong Zhu, Hao Ch |
| Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 7 . Andrew T Lenis, Vignesh Ravichandran, Samantha Brown, Syed M Alam, Andrew Katims, Hong Truong, Peter A Reisz, Samantha Vasselman, Barbara Nweji, Karen A Autio, Michael J Morris, Susan F Slovin, Dana Rathkopf, Daniel Danila, Howard I Scher, Sungmin Woo, Hebert Alberto Vargas, Vincent P Laudone, Behfar Ehdaie, Victor Reuter, Maria Arcila, Michael F Berger, Agnes Viale, Nikolaus Schultz, Anuradha Gopalan, Mark T A Donoghue, Irina Ostrovnaya, Konrad H Stopsack, David B Solit, Wassim Abi |
| Molecular classification of metastatic and recurrent endometrial endometrioid carcinoma: prognostic relevance among low- and high-stage tumours. Histopathology 2024 6 . Austin McHenry, Kelly Devereaux, Emily Ryan, Stephanie Chow, Grace Allard, Chandler C Ho, Carlos J Suarez, Ann Folkins, Eric Yang, Teri A Longacre, Vivek Charu, Brooke E Howi |
| MITO END-3: Efficacy of Avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy. Annals of oncology : official journal of the European Society for Medical Oncology 2024 5 . S Pignata, D Califano, D Lorusso, L Arenare, M Bartoletti, U De Giorgi, C Andreetta, C Pisano, G Scambia, D Lombardi, A Farolfi, S Cinieri, A Passarelli, V Salutari, C De Angelis, C Mignogna, D Priolo, E D Capoluongo, S Tamberi, G L Scaglione, V Arcangeli, R De Cecio, G Scognamiglio, F Greco, A Spina, M Turinetto, D Russo, V Carbone, C Casartelli, C Schettino, F Perro |
| A comprehensive analysis of POLE/POLD1 genomic alterations in colorectal cancer. The oncologist 2024 5 . Osama Mosalem, Tucker W Coston, Robin Imperial, Elizabeth Mauer, Christopher Thompson, Binyam Yilma, Tanios S Bekaii-Saab, Melissa Conrad Stoppler, Jason S Sta |
| Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2024 5 . M Ambrosini, B Rousseau, P Manca, O Artz, A Marabelle, T André, G Maddalena, G Mazzoli, R Intini, R Cohen, A Cercek, N H Segal, L Saltz, A M Varghese, R Yaeger, M Nusrat, Z Goldberg, G Y Ku, I El Dika, O Margalit, A Grinshpun, P Kasi, R Schilsky, A Lutfi, E Shacham-Shmueli, M Khan Afghan, L Weiss, C B Westphalen, V Conca, B Decker, G Randon, E Elez, M Fakih, A B Schrock, C Cremolini, P Jayachandran, M J Overman, S Lonardi, F Pietranton |
| Evaluation of mismatch repair and microsatellite instability status in a Chinese colorectal cancer Cohort. Asian journal of surgery 2024 1 . Peng Zhang, Anqi Wang, Ce Bian, Jing Zhang, Caifeng Jiang, Haiyang Zh |
| Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic advances in medical oncology 2024 1 16 17588359231225035. Xiang Zhang, Haizhong Ma, Yinjun He, Wenguang He, Nan Chen, Yandong Li, Weixiang Zhong, Guosheng Wu, Xile Zhou, Hanju Hua, Feng Ye, Hui Cai, Weiqin Jia |
| Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics. Cancers 2024 1 16 (1): . Qian Xi, Hidenori Kage, Miho Ogawa, Asami Matsunaga, Akira Nishijima, Kenbun Sone, Kei Kawana, Katsutoshi O |
| Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications. Cancer science 2025 1 . Yuko Chikaishi, Hiroshi Matsuoka, Eiji Sugihara, Mayu Takeda, Makoto Sumitomo, Seiji Yamada, Gaku Inaguma, Yusuke Omura, Yeongcheol Cheong, Yosuke Kobayashi, Masaya Nakauchi, Junichiro Hiro, Koji Masumori, Koki Otsuka, Hiroshi Nishihara, Koichi Suda, Hideyuki Saya, Tetsuya Takimo |
- Page last reviewed:Feb 1, 2024
- Content source: